Literature DB >> 12134511

Comparative analysis of HIV-1 resistance to AZT and AZT H-phosphonate in a cell culture.

A G Pokrovskii1, O A Plyasunova, Ya Yu Kiseleva, N M Gashnikova, N V Fedyuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12134511     DOI： 10.1023/a:1016020113950

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  12 in total

1.  Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT.

Authors:  J Machado; H Salomon; M Oliveira; C Tsoukas; A A Krayevsky; M A Wainberg
Journal:  Nucleosides Nucleotides       Date:  1999 Apr-May

2.  [The detection and quantitative determination of antigens to the human immunodeficiency virus types 1 and 2].

Authors:  N V Fediuk; E E Konovalov; V B Loktev; L V Uryvaev; S A Kuliandin; A G Pokrovskiĭ
Journal:  Vopr Virusol       Date:  1992 May-Jun

3.  [Tandem bifunctional derivatives of short oligonucleotides--inhibitors of replication of the human immunodeficiency virus in cell culture].

Authors:  O A Pliasunova; O A Mamaeva; D V Pyshnyĭ; I A Pyshnaia; E M Ivanova; P E Vorob'ev; V F Zarytova; A G Pokrovskiĭ
Journal:  Mol Biol (Mosk)       Date:  1998 Nov-Dec

4.  In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.

Authors:  Q Gao; Z X Gu; M A Parniak; X G Li; M A Wainberg
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  [Experimental use of a variant of the human immunodeficiency virus (HIV-1) with decreased sensitivity to 3'-azido-2',3'-dideoxythymidine and a study of its properties].

Authors:  L M Selimova; G A Galegov
Journal:  Dokl Akad Nauk       Date:  1995-10

6.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture.

Authors:  B A Larder; K E Coates; S D Kemp
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.

Authors:  J Balzarini; A Karlsson; M J Pérez-Pérez; M J Camarasa; E De Clercq
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

9.  Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Authors:  A K Iversen; R W Shafer; K Wehrly; M A Winters; J I Mullins; B Chesebro; T C Merigan
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.

Authors:  S F Lacey; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.